Real-World Observational Evaluation of Hair Thinning in Patients with Multiple Sclerosis Receiving Teriflunomide: Is It an Issue in Clinical Practice?

INTRODUCTION: Hair thinning occurred in 10–14% of teriflunomide-treated patients in the teriflunomide multiple sclerosis clinical development program, compared with 5% of placebo-treated patients. Our objective was to examine the clinical course of hair thinning in patients in an observational real-...

Descripción completa

Detalles Bibliográficos
Autores principales: Hendin Travis, Lori, Okai, Annette, Cavalier, Steve, Stam, Darren, Farnett, Lisa, Edwards, Keith R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283787/
https://www.ncbi.nlm.nih.gov/pubmed/30084001
http://dx.doi.org/10.1007/s40120-018-0107-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283787/
https://www.ncbi.nlm.nih.gov/pubmed/30084001
http://dx.doi.org/10.1007/s40120-018-0107-y

Ejemplares similares